Patients with questionable penicillin (beta-lactam) allergy: causes and solutions

被引:16
作者
Brockow, K. [1 ]
Wurpts, G. [2 ]
Trautmann, A. [3 ]
机构
[1] Tech Univ Munich, Klinikum Rechts Isar, Klin & Poliklin Dermatol & Allergol, Munich, Germany
[2] Univ Klin RWTH Aachen, Aachener Comprehens Allergy Ctr ACAC, Klin Dermatol & Allergol, Aachen, Germany
[3] Univ Klinikum Wurzburg, Allergiezentrum Mainfranken, Klin & Poliklin Dermatol & Allergol, Wurzburg, Germany
关键词
beta-lactam antibiotics; penicillin; allergy; beta-lactam allergy; labeling; delabeling; allergy diagnostics; DRUG ALLERGY; SKIN; HYPERSENSITIVITY; HISTORY; CHALLENGE; ANTIBIOTICS; DIAGNOSIS; CHILDREN; DOCUMENTATION; GUIDELINE;
D O I
10.5414/ALX02310E
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: In Europe, North America, and Australia, 5% to 10% of the population are now classified as penicillin (beta-lactam) allergic. Only similar to 10% of these questionable diagnoses, mostly made in childhood, can be confirmed by allergy diagnostics. Materials and methods: The aim of this review is to show causes and consequences as well as recommendations for dealing with the often questionable diagnosis of penicillin (beta-lactam) allergy (BLA). Results: An incorrect BLA diagnosis may negatively impact antibiotic treatment needed in the future, by using a less effective antibiotic or using a broad-spectrum antibiotic, for example, further exacerbating the problem of increasing antibiotic resistance. Accordingly, there is growing pressure from antibiotic stewardship programs to critically challenge the BLA diagnosis. Conservatively, a suspected BLA is reviewed by an allergist using medical history, skin testing, laboratory testing, and provocation. This clarification is costly and is not remunerated in the German health care system; that is the reason why this testing is only offered in a few specialized clinics and practically not at all in general practice. In view of thousands of affected patients, additional strategies are needed to treat patients with a low risk of hypersensitivity reaction despite suspected allergy with a beta-lactam antibiotic. In recent years, various methods have been proposed to eliminate suspected allergy as promptly as possible and directly before necessary treatment with a beta-lactam antibiotic, including standardized history (also in the form of an algorithm), skin test with immediate reading after 15 minutes, or administration of a small test dose. Investigations of small case series and also multi-center studies to date have yielded promising results in terms of feasibility and safety. Conclusion: Of the large number of patients with (questionable) BLA, most have never been tested and - if antibiotic treatment becomes necessary - simply receive an alternative antibiotic. The diagnosis of BLA therefore requires new approaches besides classical allergy testing to critically question BLA.
引用
收藏
页码:71 / 80
页数:10
相关论文
共 54 条
[1]  
Ben-Shoshan Moshe, 2017, J Pediatr, V188, P308, DOI 10.1016/j.jpeds.2017.06.061
[2]   Tackling inpatient penicillin allergies: Assessing tools for antimicrobial stewardship [J].
Blumenthal, Kimberly G. ;
Wickner, Paige G. ;
Hurwitz, Shelley ;
Pricco, Nicholas ;
Nee, Alexandra E. ;
Laskowski, Karl ;
Shenoy, Erica S. ;
Walensky, Rochelle P. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 140 (01) :154-+
[3]   Drug allergy passport and other documentation for patients with drug hypersensitivity - An ENDA/EAACI Drug Allergy Interest Group Position Paper [J].
Brockow, K. ;
Aberer, W. ;
Atanaskovic-Markovic, M. ;
Bavbek, S. ;
Bircher, A. ;
Bilo, B. ;
Blanca, M. ;
Bonadonna, P. ;
Burbach, G. ;
Calogiuri, G. ;
Caruso, C. ;
Celik, G. ;
Cernadas, J. ;
Chiriac, A. ;
Demoly, P. ;
Oude Elberink, J. N. G. ;
Fernandez, J. ;
Gomes, E. ;
Garvey, L. H. ;
Gooi, J. ;
Gotua, M. ;
Grosber, M. ;
Kauppi, P. ;
Kvedariene, V. ;
Laguna, J. J. ;
Makowska, J. S. ;
Mosbech, H. ;
Nakonechna, A. ;
Papadopolous, N. G. ;
Ring, J. ;
Romano, A. ;
Rockmann, H. ;
Sargur, R. ;
Sedlackova, L. ;
Sigurdardottir, S. ;
Schnyder, B. ;
Storaas, T. ;
Torres, M. ;
Zidarn, M. ;
Terreehorst, I. .
ALLERGY, 2016, 71 (11) :1533-1539
[4]  
Brockow K., 2020, Allergo J, V29, P68, DOI 10.1007/s15007-020-2589-z
[5]  
Brockow K., 2018, Drug Allergy Testing, P19, DOI [10.1016/B978-0-323-48551-7.00003-1, DOI 10.1016/B978-0-323-48551-7.00003-1]
[6]   Cutaneous drug hypersensitivity: developments and controversies [J].
Brockow, Knut ;
Pfuetzner, Wolfgang .
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 19 (04) :308-318
[7]   Triage Strategies for Clarifying Reported Betalactam Allergy [J].
Brockow, Knut .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019, 7 (03) :1066-1067
[8]   EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity [J].
Brockow, Knut ;
Ardern-Jones, Michael R. ;
Mockenhaupt, Maja ;
Aberer, Werner ;
Barbaud, Annick ;
Caubet, Jean-Christoph ;
Spiewak, Radoslaw ;
Torres, Maria Jose ;
Mortz, Charlotte G. .
ALLERGY, 2019, 74 (01) :14-27
[9]   Guideline to Allergy Diagnosis of Hypersensitive Reactions to Medicines [J].
Brockow, Knut ;
Przybilla, Bernhard ;
Aberer, Werner ;
Bircher, Andreas J. ;
Brehler, Randolf ;
Dickel, Heinrich ;
Fuchs, Thomas T. ;
Jakob, Thilo T. ;
Lange, Lars ;
Pfuetzner, Wolfgang ;
Mockenhaupt, Maja ;
Ott, Hagen ;
Pfaar, Oliver ;
Ring, Johannes ;
Sachs, Bernhardt ;
Sitter, Helmut ;
Trautmann, Axel ;
Treudler, Regina ;
Wedi, Bettina ;
Worm, Margitta ;
Wurpts, Gerda ;
Zuberbier, Torsten ;
Merk, Hans F. .
ALLERGO JOURNAL, 2015, 24 (03) :44-55
[10]  
Busch, 2020, ALLERGO J INT, V29, P174, DOI [10.1007/s40629-020-00135-5, DOI 10.1007/S40629-020-00135-5]